TrialsWest Expands with New Clinical Trial Site
Filed with ASX · · 3 pages · English
Summary by 6ix AI
Resonance Health Ltd announces the expansion of TrialsWest with a new clinical trial site in Mandurah, Western Australia, expected to open soon. This new site will significantly increase participant capacity and support ongoing major pharmaceutical trials managed by Resonance Health. The expansion aligns with the company's strategy to grow its clinical trial operations in densely populated areas with low establishment costs. CEO Andrew Harrison expressed optimism about the growth opportunities this new site presents for the TrialsWest business.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Resonance Health
- Half Yearly Report and Accounts
- Non-deal Investor Roadshow Presentation
- Resonance Contracted by Major Global Pharma
- Trading Halt
- Full Year Results Presentation
Later from Resonance Health
- Appendix 4E & Full Year Statutory Accounts
- FY25 Full Year Results & FY26 Guidance Investor Presentation
- Investor Strategy Day Presentation
- AGM Presentation
- Quarterly Activities/Appendix 4C Cash Flow Report
Follow Resonance Health into a list and get an email when it puts out news.
Follow Resonance Health